Merck’s extensive clinical development program for the TROP2 antibody-drug conjugate (ADC) sac-TMT already includes 17 international Phase 3 trials. But…

Bob covers medical expenses, focusing on health insurance and hospitals. His story delves into Medicare Advantage, opaque prescription drug benefits,…

A conservation approach once hailed as a global model for helping humans and predators coexist may be losing ground due…

Europe’s first study reveals that thousands of health and social care workers are regularly exposed to cancer risk factors, with…

Black and Latinx adults with cognitive impairment have lower amyloid accumulation associated with Alzheimer’s disease despite higher rates of dementia,…